If you need more lookups,
subscriptions start at $34 USD/month.
James Linder Location
Omaha, NE, US
James Linder Work
Co-Founder @ (December 2011 - Present)
Co-Founder and Managing Director @ (January 2007 - Present)
Professor, Pathology and Microbiology @ (November 1983 - Present)
Board Advisor @ (July 2025 - Present)
Chief Executive Officer and Board Chair @ (August 2018 - June 2025)
Board Chair @ (July 2017 - August 2020)
Chief Strategist @ (April 2015 - August 2018)
President @ (May 2011 - August 2018)
Interim President @ (May 2014 - April 2015)
Chief Medical Officer @ (July 2013 - February 2016)
Chief Medical Officer @ Constituion Medical Investors (January 2009 - July 2013)
Senior Vice President and and or Chief Medical Officer @ Cytyc (November 1995 - October 2007)
James Linder Education
Duke University
Residency (Pathology)
1980-1982
University of Nebraska Medical Center
Doctor of Medicine (M.D.)
1977-1980
James Linder Skills
Business Development
Clinical Trials
Business Planning
FDA
Angel Investing
Medical Diagnostics
Not for Profit
Molecular Diagnostics
Commercialization
Medical Devices
Hematology
Hardware Diagnostics
Cancer
Microbiology
Leadership
Laboratory
Clinical Research
Research
Genomics
Pathology
Infectious Diseases
Biotechnology
Education
Healthcare
Strategic Planning
Lifesciences
Entrepreneurship
Business Strategy
Management
Project Management
Technology Transfer
Marketing Strategy
Hospitals
Sales
Microsoft Office
Strategy
James Linder Summary
James Linder, based in Omaha, NE, US, is currently a Co-Founder at Tethon 3D. James Linder brings experience from previous roles at Linseed Capital, University of Nebraska Medical Center and Nebraska Medicine. James Linder holds a 1980 - 1982 Residency in Pathology @ Duke University. With a robust skill set that includes Business Development, Clinical Trials, Business Planning, FDA, Angel Investing and more. James Linder has 4 emails and 2 mobile phone numbers on RocketReach.
Looking for a different James Linder?
Find contact details for 700 million professionals.